Display Settings:

Format

Send to:

Choose Destination
    Gastroenterol Clin North Am. 2008 Jun;37(2):397-410, vi-vii.

    Enteric autoantibodies and gut motility disorders.

    Source

    Mayo Clinic, Rochester, MN 55905, USA.

    Abstract

    Increasing evidence suggests that a subset of gastrointestinal motility disorders is associated with the presence of circulating antibodies. These antibodies are directed against various molecular targets, the best known being anti-neuronal nuclear antibody (ANNA-1 or anti-Hu) associated with paraneoplastic motility disorders. There is also evidence that the presence of distinct autoantibody profiles is associated with non-paraneoplastic motility disorders. This review focuses on the types of antibodies associated with gastrointestinal motility disorders and the significance of these antibodies. Algorithms are suggested for the work-up and treatment of patients with circulating antibodies associated with gastrointestinal motility disorders.

    PMID:
    18499027
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2448392
    Free PMC Article

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk